{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:58:47Z","timestamp":1790909927359,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.174011","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T07:28:55Z","timestamp":1615274935000},"page":"174011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model"],"prefix":"10.1016","volume":"899","author":[{"given":"Hye-Eun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuSik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyae Gyeong","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174011_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","article-title":"FoxOs at the crossroads of cellular metabolism, differentiation, and transformation","volume":"117","author":"Accili","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174011_bib2","first-page":"E718","article-title":"Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice","volume":"295","author":"Altomonte","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2021.174011_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174011_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tem.2005.03.010","article-title":"FoxO proteins in insulin action and metabolism","volume":"16","author":"Barthel","year":"2005","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2021.174011_bib5","first-page":"E23","article-title":"Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus","volume":"280","author":"Boden","year":"2001","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2021.174011_bib6","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/onc.2008.21","article-title":"The FoxO code","volume":"27","author":"Calnan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174011_bib7","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1016\/j.cub.2007.01.008","article-title":"FoxO transcription factors","volume":"17","author":"Carter","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2021.174011_bib8","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1074\/jbc.M212307200","article-title":"A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids","volume":"278","author":"Chavez","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174011_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/diabetes.54.3.727","article-title":"Functional and molecular defects of pancreatic islets in human type 2 diabetes","volume":"54","author":"Del Guerra","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174011_bib10","doi-asserted-by":"crossref","first-page":"26861","DOI":"10.1074\/jbc.M110.134023","article-title":"Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia","volume":"285","author":"Haeusler","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174011_bib11","doi-asserted-by":"crossref","first-page":"30169","DOI":"10.1074\/jbc.M004898200","article-title":"Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix\/forkhead proteins","volume":"275","author":"Hall","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174011_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1677\/jme.0.0300253","article-title":"Nutritional and hormonal factors control the gene expression of Foxos, the mammalian homologues of DAF-16","volume":"30","author":"Imae","year":"2003","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.174011_bib13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1172\/JCI200216857","article-title":"The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic \u03b2 cell growth","volume":"110","author":"Kitamura","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174011_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2005.08.004","article-title":"FoxO1 protects against pancreatic \u03b2 cell failure through NeuroD and MafA induction","volume":"2","author":"Kitamura","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2021.174011_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.09.045","article-title":"Selective inhibition of FoxO1 activator\/repressor balance modulates hepatic glucose handling","volume":"171","author":"Langlet","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174011_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174011_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2337\/db07-0595","article-title":"Inhibition of FoxO1 protects pancreatic islet \u03b2-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis","volume":"57","author":"Martinez","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174011_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2021.174011_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2443.2012.01625.x","article-title":"Analysis of FoxO1-regulated genes using FoxO1-deficeint pancreatic \u03b2 cells","volume":"17","author":"Miyazaki","year":"2012","journal-title":"Gene Cell."},{"key":"10.1016\/j.ejphar.2021.174011_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/mol.110.065714","article-title":"Discovery of novel Forkhead box 1 inhibitors for treating type 2 diabetes: improvements of fasting glycemia in diabetic db\/db mice","volume":"78","author":"Nagashima","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174011_bib21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI200112876","article-title":"The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression","volume":"108","author":"Nakae","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174011_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng890","article-title":"Regulation of insulin action and pancreatic \u03b2-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1","volume":"32","author":"Nakae","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2021.174011_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI24967","article-title":"Role of the forkhead protein FoxO1 in \u03b2 cell compensation to insulin resistance","volume":"116","author":"Okamoto","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174011_bib24","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1210\/en.2006-0541","article-title":"Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism","volume":"147","author":"Qu","year":"2006","journal-title":"Endocrinol"},{"key":"10.1016\/j.ejphar.2021.174011_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.174011_bib26","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/db05-0705","article-title":"Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action","volume":"55","author":"Samuel","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174011_bib27","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.174011_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2010.07.018","article-title":"Effects of the novel Foxo1 inhibitor AS170827 on plasma glucose and triglyceride levels in diabetic db\/db mice","volume":"645","author":"Tanaka","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174011_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2021.174011_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng1787","article-title":"Total insulin and IGF-1 resistance in pancreatic \u03b2 cells causes overt diabetes","volume":"38","author":"Ueki","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2021.174011_bib31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/db07-0714","article-title":"Increased expression and activity of the transcription factor Foxo1 in nonalcoholic steatohepatitis","volume":"57","author":"Valenti","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174011_bib32","doi-asserted-by":"crossref","first-page":"49676","DOI":"10.1074\/jbc.M208756200","article-title":"Protein kinase B\/Akt prevents fatty-acid-induced apoptosis in pancreatic \u03b2-cells (INS-1)","volume":"277","author":"Wrede","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174011_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/en.2011-1527","article-title":"Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice","volume":"153","author":"Zhang","year":"2012","journal-title":"Endocrinol"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:48:33Z","timestamp":1757976513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921001643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":33,"alternative-id":["S0014299921001643"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel FoxO1 inhibitor, JY-2, ameliorates palmitic acid-induced lipotoxicity and gluconeogenesis in a murine model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174011"}}